Sandra Sitar
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 2%
- Viral Infections and Outbreaks Research
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Viral Infections and Outbreaks Research 6
- SARS-CoV-2 and COVID-19 Research 1
- Virology 2
- HIV Research and Treatment 2
- Co-authors
- Barney S. Graham (4 shared papers)John R. Mascola (4 shared papers)Karin Bok (1 shared paper)Julie E. Ledgerwood (4 shared papers)Mary E. Enama (3 shared papers)Robert T. Bailer (3 shared papers)Gary J. Nabel (3 shared papers)Zonghui Hu (3 shared papers)
- Journals
- The Lancet (4 papers)The Journal of Infectious Diseases (3 papers)Nature Medicine (2 papers)Science (2 papers)Science Translational Medicine (1 paper)
- Partner nations
- United StatesItaly
In The Last Decade
Sandra Sitar
20 papers receiving 3.0k citations
Sandra Sitar's Hit Papers
Peers
Comparison fields: 5 of 67
- Virology 330
- Infectious Diseases 665
- Public Health, Environmental and Occupational Health 878
- Epidemiology 310
- Immunology 127
Countries citing papers authored by Sandra Sitar
This map shows the geographic impact of Sandra Sitar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Sitar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Sitar more than expected).
Fields of papers citing papers by Sandra Sitar
This network shows the impact of papers produced by Sandra Sitar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Sitar. The network helps show where Sandra Sitar may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandra Sitar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine Hit paper breakdown → | 2013 | 635 |
| 2 | A proof of concept for structure-based vaccine design targeting RSV in humans Hit paper breakdown → | 2019 | 282 |
| 3 | 2017 | 255 | |
| 4 | 2014 | 243 | |
| 5 | 2015 | 222 | |
| 6 | 2014 | 217 | |
| 7 | 2018 | 194 | |
| 8 | 2021 | 192 | |
| 9 | Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial Hit paper breakdown → | 2022 | 135 |
| 10 | 2013 | 115 | |
| 11 | 2014 | 111 | |
| 12 | 2014 | 106 | |
| 13 | 2019 | 101 | |
| 14 | 2019 | 89 | |
| 15 | 2023 | 73 | |
| 16 | 2022 | 71 | |
| 17 | 2015 | 23 | |
| 18 | 2010 | 16 | |
| 19 | 2024 | 10 | |
| 20 | 2022 | 3 |
About Sandra Sitar
Sandra Sitar is a scholar working on Infectious Diseases, Virology, Epidemiology, Public Health, Environmental and Occupational Health and Genetics, having authored 20 papers that have together received 3.1k indexed citations. Recurring topics across this work include Viral Infections and Outbreaks Research (6 papers), Influenza Virus Research Studies (4 papers), HIV Research and Treatment (2 papers), Mosquito-borne diseases and control (2 papers), Virus-based gene therapy research (1 paper), Respiratory viral infections research (1 paper), Malaria Research and Control (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Virology (330 citations), Infectious Diseases (665 citations), Public Health, Environmental and Occupational Health (878 citations), Epidemiology (310 citations) and Immunology (127 citations). Sandra Sitar has collaborated with scholars based in United States and Italy. Frequent co-authors include Barney S. Graham, John R. Mascola, Karin Bok, Julie E. Ledgerwood, Mary E. Enama, Robert T. Bailer, Gary J. Nabel, Zonghui Hu, Richard A. Koup and Lee-Jah Chang. Their work appears in journals such as The Lancet, The Journal of Infectious Diseases, Nature Medicine, Science and Science Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.